Mechanism of Action and Implication of Naphthoquinone as Potent Anti-trypanosomal Drugs

López, L.L.I.; Nery, F.S.D.; Silva, B.S.Y.; Sáenz, G.A. Naphthoquinones: Biological properties and synthesis of lawsone and derivatives-A structured review. Vitae, 2014, 21(3), 248-258.

Dulo, B.; Phan, K.; Githaiga, J.; Raes, K.; De Meester, S. Natural quinone dyes: A review on structure, extraction techniques, analysis and application potential. Waste Biomass Valoriz., 2021, 12(12), 6339-6374.
[http://dx.doi.org/10.1007/s12649-021-01443-9]

Gong, X.; Gutala, R.; Jaiswal, A.K. Quinone oxidoreductases and vitamin K metabolism. Vitam. Horm., 2008, 78, 85-101.
[http://dx.doi.org/10.1016/S0083-6729(07)00005-2] [PMID: 18374191]

Färnert, A.; Lindberg, J.; Gil, P.; Swedberg, G.; Berqvist, Y.; Thapar, M.M.; Lindegårdh, N.; Berezcky, S.; Björkman, A. Evidence of Plasmodium falciparum malaria resistant to atovaquone and proguanil hydrochloride: Case reports. BMJ, 2003, 326(7390), 628-629.
[http://dx.doi.org/10.1136/bmj.326.7390.628] [PMID: 12649236]

Krause, P.J.; Lepore, T.; Sikand, V.K.; Gadbaw, J., Jr; Burke, G.; Telford, S.R., III; Brassard, P.; Pearl, D.; Azlanzadeh, J.; Christianson, D.; McGrath, D.; Spielman, A. Atovaquone and azithromycin for the treatment of babesiosis. N. Engl. J. Med., 2000, 343(20), 1454-1458.
[http://dx.doi.org/10.1056/NEJM200011163432004] [PMID: 11078770]

Djurković, D.O.; Milenković, V.; Nikolić, A.; Bobić, B.; Grujić, J. Efficacy of atovaquone combined with clindamycin against murine infection with a cystogenic (Me49) strain of Toxoplasma gondii. J. Antimicrob. Chemother., 2002, 50(6), 981-987.
[http://dx.doi.org/10.1093/jac/dkf251] [PMID: 12461021]

Sharifiyazdi, H.; Namazi, F.; Oryan, A.; Shahriari, R.; Razavi, M. Point mutations in the Theileria annulata cytochrome B gene is associ-ated with buparvaquone treatment failure. Vet. Parasitol., 2012, 187(3-4), 431-435.
[http://dx.doi.org/10.1016/j.vetpar.2012.01.016] [PMID: 22305656]

Kumar, S.; Gupta, A.K.; Pal, Y.; Dwivedi, S.K. In-vivo therapeutic efficacy trial with artemisinin derivative, buparvaquone and imidocarb dipropionate against Babesia equi infection in donkeys. J. Vet. Med. Sci., 2003, 65(11), 1171-1177.
[http://dx.doi.org/10.1292/jvms.65.1171] [PMID: 14665744]

Ventura, P.A.; De Castro, P.S. The trypanocidal activity of naphthoquinones: A review. Molecules, 2009, 14(11), 4570-4590.
[http://dx.doi.org/10.3390/molecules14114570] [PMID: 19924086]

Croft, S.L.; Hogg, J.; Gutteridge, W.E.; Hudson, A.T.; Randall, A.W. The activity of hydroxynaphthoquinones against Leishmania do-novani. J. Antimicrob. Chemother., 1992, 30(6), 827-832.
[http://dx.doi.org/10.1093/jac/30.6.827] [PMID: 1289357]

Reimão, J.Q.; Colombo, F.A.; Pereira, C.V.L.; Tempone, A.G. Effectiveness of liposomal buparvaquone in an experimental hamster model of Leishmania (L.) infantum chagasi. Exp. Parasitol., 2012, 130(3), 195-199.
[http://dx.doi.org/10.1016/j.exppara.2012.01.010] [PMID: 22281156]

Jamal, Q.; Khan, N.H.; Wahid, S.; Awan, M.M.; Sutherland, C.; Shah, A. In-vitro sensitivity of Pakistani Leishmania tropica field isolate against buparvaquone in comparison to standard anti-leishmanial drugs. Exp. Parasitol., 2015, 154, 93-97.
[http://dx.doi.org/10.1016/j.exppara.2015.04.017] [PMID: 5911243]

Da Costa, S.T.A.; Galisteo, A.J., Jr; Lindoso, J.A.L.; Barbosa, L.R.S.; Tempone, A.G. Nanoliposomal buparvaquone immunomodulates Leishmania infantum-infected macrophages and is highly effective in a murine model. Antimicrob. Agents Chemother., 2017, 61(4), e02297-e16.
[http://dx.doi.org/10.1128/AAC.02297-16] [PMID: 28167544]

Adl, S.M.; Simpson, A.G.B.; Lane, C.E.; Lukeš, J.; Bass, D.; Bowser, S.S.; Brown, M.W.; Burki, F.; Dunthorn, M.; Hampl, V.; Heiss, A.; Hoppenrath, M.; Lara, E.; le Gall, L.; Lynn, D.H.; McManus, H.; Mitchell, E.A.D.; Mozley, S.S.E.; Parfrey, L.W.; Pawlowski, J.; Rueck-ert, S.; Shadwick, L.; Schoch, C.L.; Smirnov, A.; Spiegel, F.W. The revised classification of eukaryotes. J. Eukaryot. Microbiol., 2012, 59(5), 429-514.
[http://dx.doi.org/10.1111/j.1550-7408.2012.00644.x] [PMID: 23020233]

Stuart, K.; Brun, R.; Croft, S.; Fairlamb, A.; Gürtler, R.E.; McKerrow, J.; Reed, S.; Tarleton, R. Kinetoplastids: Related protozoan patho-gens, different diseases. J. Clin. Invest., 2008, 118(4), 1301-1310.
[http://dx.doi.org/10.1172/JCI33945] [PMID: 18382742]

Brun, R.; Blum, J.; Chappuis, F.; Burri, C. Human African trypanosomiasis. Lancet, 2010, 375(9709), 148-159.
[http://dx.doi.org/10.1016/S0140-6736(09)60829-1] [PMID: 19833383]

Rassi, A., Jr; Rassi, A.; De Rezende, M.J. American trypanosomiasis (Chagas disease). Infect. Dis. Clin. North Am., 2012, 26(2), 275-291.
[http://dx.doi.org/10.1016/j.idc.2012.03.002] [PMID: 22632639]

Available from: https://www.cdc.gov/parasites/sleepingsickness/ Available from: https://www.cdc.gov/parasites/chagas/ Accessed on March 10, 2022

Kennedy, P.G.E. Human African trypanosomiasis of the CNS: Current issues and challenges. J. Clin. Invest., 2004, 113(4), 496-504.
[http://dx.doi.org/10.1172/JCI200421052] [PMID: 14966556]

Kennedy, P.G.E. Clinical features, diagnosis, and treatment of human African trypanosomiasis (sleeping sickness). Lancet Neurol., 2013, 12(2), 186-194.
[http://dx.doi.org/10.1016/S1474-4422(12)70296-X] [PMID: 23260189]

WHO. Human African trypanosomiasis: Number of new cases drops to historically low level in 50 years. 2010. Available form: http://www.who.int/neglected_diseases/integrated_media/integrated_media_hat_june_2010/en/index.html [Accessed on March 10, 2022].

Franco, J.R.; Cecchi, G.; Priotto, G.; Paone, M.; Diarra, A.; Grout, L.; Mattioli, R.C.; Argaw, D. Monitoring the elimination of human African trypanosomiasis: Update to 2014. PLoS Negl. Trop. Dis., 2017, 11(5), e0005585.
[http://dx.doi.org/10.1371/journal.pntd.0005585] [PMID: 28531222]

Coetzer, A.W.; Tustin, R.C. Infectious diseases of livestock; Oxford University Press: Oxford, 2005.

Radwanska, M.; Vereecke, N.; Deleeuw, V.; Pinto, J.; Magez, S. Salivarian trypanosomosis: A review of parasites involved, their global distribution and their interaction with the innate and adaptive mammalian host immune system. Front. Immunol., 2018, 9, 2253.
[http://dx.doi.org/10.3389/fimmu.2018.02253] [PMID: 30333827]

Perez, C.J.; Lymbery, A.J.; Thompson, R.C.A. Reactivation of chagas disease: Implications for global health. Trends Parasitol., 2015, 31(11), 595-603.
[http://dx.doi.org/10.1016/j.pt.2015.06.006] [PMID: 26458782]

Rassi, A., Jr; Rassi, A.; Marin, N.J.A. Chagas disease. Lancet, 2010, 375(9723), 1388-1402.
[http://dx.doi.org/10.1016/S0140-6736(10)60061-X] [PMID: 20399979]

Staquicini, D.I.; Martins, R.M.; Macedo, S.; Sasso, G.R.S.; Atayde, V.D.; Juliano, M.A.; Yoshida, N. Role of GP82 in the selective bind-ing to gastric mucin during oral infection with Trypanosoma cruzi. PLoS Negl. Trop. Dis., 2010, 4(3), e613.
[http://dx.doi.org/10.1371/journal.pntd.0000613] [PMID: 20209152]

Yoshida, N.; Tyler, K.M.; Llewellyn, M.S. Invasion mechanisms among emerging food-borne protozoan parasites. Trends Parasitol., 2011, 27(10), 459-466.
[http://dx.doi.org/10.1016/j.pt.2011.06.006] [PMID: 21840261]

Echeverria, L.E.; Morillo, C.A. American trypanosomiasis (Chagas disease). Infect. Dis. Clin. North Am., 2019, 33(1), 119-134.
[http://dx.doi.org/10.1016/j.idc.2018.10.015] [PMID: 30712757]

Merritt, C.; Silva, L.E.; Tanner, A.L.; Stuart, K.; Pollastri, M.P. Kinases as druggable targets in trypanosomatid protozoan parasites. Chem. Rev., 2014, 114(22), 11280-11304.
[http://dx.doi.org/10.1021/cr500197d] [PMID: 26443079]

WHO. Chagas disease (also known as American trypanosomiasis). 2020. Available from: https://www.who.int/news-room/fact-sheets/detail/chagas-disease-(american-trypanosomiasis) [Accessed on January 30, 2022].

Desquesnes, M.; Dargantes, A.; Lai, D.H.; Lun, Z.R.; Holzmuller, P.; Jittapalapong, S. Trypanosoma evansi and surra: A review and per-spectives on transmission, epidemiology and control, impact, and zoonotic aspects. BioMed Res. Int., 2013, 2013, 1-20.
[http://dx.doi.org/10.1155/2013/321237] [PMID: 24151595]

Carnes, J.; Anupama, A.; Balmer, O.; Jackson, A.; Lewis, M.; Brown, R.; Cestari, I.; Desquesnes, M.; Gendrin, C.; Hertz-Fowler, C.; Imamura, H.; Ivens, A.; Kořený, L.; Lai, D.H.; MacLeod, A.; McDermott, S.M.; Merritt, C.; Monnerat, S.; Moon, W.; Myler, P.; Phan, I.; Ramasamy, G.; Sivam, D.; Lun, Z.R.; Lukeš, J.; Stuart, K.; Schnaufer, A. Genome and phylogenetic analyses of Trypanosoma evansi re-veal extensive similarity to T. brucei and multiple independent origins for dyskinetoplasty. PLoS Negl. Trop. Dis., 2015, 9(1), e3404.
[http://dx.doi.org/10.1371/journal.pntd.0003404] [PMID: 25568942]

Ou, Y.C.; Giroud, C.; Baltz, T. Kinetoplast DNA analysis of four Trypanosoma evansi strains. Mol. Biochem. Parasitol., 1991, 46(1), 97-102.
[http://dx.doi.org/10.1016/0166-6851(91)90203-I] [PMID: 1677160]

Birhanu, H.; Gebrehiwot, T.; Goddeeris, B.M.; Büscher, P.; Van Reet, N. New Trypanosoma evansi type B isolates from Ethiopian drom-edary camels. PLoS Negl. Trop. Dis., 2016, 10(4), e0004556.
[http://dx.doi.org/10.1371/journal.pntd.0004556] [PMID: 27035661]

Desquesnes, M.; Holzmuller, P.; Lai, D.H.; Dargantes, A.; Lun, Z.R.; Jittaplapong, S. Trypanosoma evansi and surra: A review and per-spectives on origin, history, distribution, taxonomy, morphology, hosts, and pathogenic effects. BioMed Res. Int., 2013, 2013, 194176.
[http://dx.doi.org/10.1155/2013/194176] [PMID: 24024184]

Hoare, C.A. Vampire bats as vectors and hosts of equine and bovine trypanosomes. Acta Trop., 1965, 22(3), 204-216.
[PMID: 4379528]

Kumar, R.; Kumar, S.; Khurana, S.K.; Yadav, S.C. Development of an antibody-ELISA for seroprevalence of Trypanosoma evansi in equids of North and North-western regions of India. Vet. Parasitol., 2013, 196(3-4), 251-257.
[http://dx.doi.org/10.1016/j.vetpar.2013.04.018] [PMID: 23664710]

Kumar, R.; Jain, S.; Kumar, S.; Sethi, K.; Kumar, S.; Tripathi, B.N. Impact estimation of animal trypanosomosis (surra) on livestock productivity in India using simulation model: Current and future perspective. Vet. Parasitol. Reg. Stud. Rep., 2017, 10, 1-12.
[http://dx.doi.org/10.1016/j.vprsr.2017.06.008] [PMID: 31014579]

Joshi, P.P.; Truc, P.; Salkar, H.R.; Dani, V.S.; Shegokar, V.R.; Bhargava, A.; Powar, R.M.; Herder, S.; Jannin, J.; Katti, R. Human trypa-nosomiasis caused by Trypanosoma evansi in India: The first case report. Am. J. Trop. Med. Hyg., 2005, 73(3), 491-495.
[http://dx.doi.org/10.4269/ajtmh.2005.73.491] [PMID: 16172469]

Roy, N.; Nageshan, R.K.; Pallavi, R.; Chakravarthy, H.; Chandran, S.; Kumar, R.; Gupta, A.K.; Singh, R.K.; Yadav, S.C.; Tatu, U. Prote-omics of Trypanosoma evansi infection in rodents. PLoS One, 2010, 5(3), e9796.
[http://dx.doi.org/10.1371/journal.pone.0009796] [PMID: 20339546]

Van Vinh Chau, N.; Buu Chau, L.; Desquesnes, M.; Herder, S.; Phu Huong Lan, N.; Campbell, J.I.; Van Cuong, N.; Yimming, B.; Cha-lermwong, P.; Jittapalapong, S.; Ramon Franco, J.; Tri Tue, N.; Rabaa, M.A.; Carrique-Mas, J.; Pham Thi Thanh, T.; Tran Vu Thieu, N.; Berto, A.; Thi Hoa, N.; Van Minh, H.N.; Canh, T.N.; Khac, C.N.; Wills, B.; Tinh, H.T.; Thwaites, G.E.; Yacoub, S.; Baker, S. A clinical and epidemiological investigation of the first reported human infection with the zoonotic parasite Trypanosoma evansi in Southeast Asia. Clin. Infect. Dis., 2016, 62(8), 1002-1008.
[http://dx.doi.org/10.1093/cid/ciw052] [PMID: 26908809]

Kumar, R.; Sharma, P.; Kumar Gaur, D.; Jain, S. Recent development in identification of potential novel therapeutic targets against trypa-nosomatids. Curr. Top. Med. Chem., 2016, 16(20), 2303-2315.
[http://dx.doi.org/10.2174/1568026616666160413125453] [PMID: 27072714]

Babula, P.; Adam, V.; Havel, L.; Kizek, R. Noteworthy secondary metabolites naphthoquinones-Their occurrence, pharmacological properties and analysis. Curr. Pharm. Anal., 2009, 5(1), 47-68.
[http://dx.doi.org/10.2174/157341209787314936]

Vaverkova, V.; Vrana, O.; Adam, V.; Pekarek, T.; Jampilek, J.; Babula, P. The study of naphthoquinones and their complexes with DNA by using Raman spectroscopy and surface enhanced Raman spectroscopy: New insight into interactions of DNA with plant secondary metabolites. BioMed Res. Int., 2014, 2014, 1-12.
[http://dx.doi.org/10.1155/2014/461393] [PMID: 25045679]

(a) De Castro, S.L.; Pinto, M.C.F.R.; Pinto, A.V. Screening of natural and synthetic drugs against Trypanosoma cruzi. 1. Establishing a structure/activity relationship. Microbios, 1994, 78(315), 83-90.
[PMID: 8047025];
(b) Pinto, A.V.; Pinto, C.N. Pinto, Mdo.C.; Rita, R.S.; Pezzella, C.A.; De Castro, S.L. Trypanocidal activity of synthetic heterocyclic de-rivatives of active quinones from Tabebuia sp. Arzneimittelforschung, 1997, 47(1), 74-79.
[PMID: 9037448]

(a) Pinto, C.N.; Dantas, A.P.; De Moura, K.C.; Emery, F.S.; Polequevitch, P.F.; Pinto, M.C.; De Castro, S.L.; Pinto, A.V. Chemical reac-tivity studies with naphthoquinones from Tabebuia with anti-trypanosomal efficacy. Arzneimittelforschung, 2000, 50(12), 1120-1128.
[PMID: 11190779];
(b) Moura, K.C.G.; Emery, F.S.; Neves, P.C.; Dantas, A.P.; Salomão, K. Synthesis and trypanocidal activity of naphthoquinones isolated from Tabebuia and heterocyclic derivatives: A review from an interdisciplnary study. J. Braz. Chem. Soc., 12(3), 325-338.;
(c) De Moura, K.C.G.; Salomão, K.; Menna, B.R.F.S.; Emery, F.S.; Pinto, M.C.F.R.; Pinto, A.V.; De Castro, S.L. Studies on the trypano-cidal activity of semi-synthetic pyran[b-4,3]naphtho[1,2-d]imidazoles from β-lapachone. Eur. J. Med. Chem., 2004, 39(7), 639-645.
[http://dx.doi.org/10.1016/j.ejmech.2004.02.015] [PMID: 15236845];
(d) Menna-Barreto, R.F.S.; Henriques-Pons, A.; Pinto, A.V.; Morgado-Diaz, J.A.; Soares, M.J.; De Castro, S.L. Effect of a β-lapachone-derived naphthoimidazole on Trypanosoma cruzi: Identification of target organelles. J. Antimicrob. Chemother., 2005, 56(6), 1034-1041.
[http://dx.doi.org/10.1093/jac/dki403] [PMID: 16269551];
(e) Menna, B.R.F.S.; Corrêa, J.R.; Pinto, A.V.; Soares, M.J.; De Castro, S.L. Mitochondrial disruption and DNA fragmentation in Trypa-nosoma cruzi induced by naphthoimidazoles synthesized from β-lapachone. Parasitol. Res., 2007, 101(4), 895-905.
[http://dx.doi.org/10.1007/s00436-007-0556-1] [PMID: 17546464];
(f) Salas, C.; Tapia, R.A.; Ciudad, K.; Armstrong, V.; Orellana, M.; Kemmerling, U.; Ferreira, J.; Maya, J.D.; Morello, A Trypanosoma cruzi: Activities of lapachol and α- and β-lapachone derivatives against epimastigote and trypomastigote forms. Bioorg. Med. Chem., 2008, 16(2), 668-674.
[http://dx.doi.org/10.1016/j.bmc.2007.10.038] [PMID: 18029184];
(g) Da Silva, E.N. Jr; Menna, B.R.F.S.; Pinto, M.C.F.R.; Silva, R.S.F.; Teixeira, D.V.; De Souza, M.C.B.V.; De Simone, C.A.; De Castro, S.L.; Ferreira, V.F.; Pinto, A.V. Naphthoquinoidal [1,2,3]- triazole, a new structural moiety active against Trypanosoma cruzi Eur. J. Med. Chem., 2008, 43(8), 1774-1780.
[http://dx.doi.org/10.1016/j.ejmech.2007.10.015] [PMID: 18045742];
(h) Silva Júnior, E.N.; Moura, M.A.B.F.; Pinto, A.V.; Pinto, M.C.F.R.; Souza, M.C.B.V.; Araújo, A.J.; Pessoa, C.; CostaLotufo, L.V.; Montenegro, R.C.; Moraes, M.O.; Ferreira, V.F.; Goulart, M.O.F. Cytotoxic, trypanocidal activities and physicochemical parameters of nor-²-lapachone-based 1,2,3-triazoles. J. Braz. Chem. Soc, 2009, 20(4), 635-643.
[http://dx.doi.org/10.1590/S0103-50532009000400007]

(a) Da Silva, E.N.; De Melo, I.M.M.; Diogo, E.B.T.; Costa, V.A.; De Souza Filho, J.D.; Valença, W.O.; Camara, C.A.; De Oliveira, R.N.; De Araujo, A.S.; Emery, F.S.; dos Santos, M.R.; De Simone, C.A.; Menna, B.R.F.S.; De Castro, S.L. On the search for potential anti-Trypanosoma cruzi drugs: Synthesis and biological evaluation of 2-hydroxy-3-methylamino and 1,2,3-triazolic naphthoquinoidal com-pounds obtained by click chemistry reactions. Eur. J. Med. Chem., 2012, 52, 304-312.
[http://dx.doi.org/10.1016/j.ejmech.2012.03.039] [PMID: 22483633];
(b) Diogo, E.B.T.; Dias, G.G.; Rodrigues, B.L.; Guimarães, T.T.; Valença, W.O.; Camara, C.A.; De Oliveira, R.N.; da Silva, M.G.; Fer-reira, V.F.; De Paiva, Y.G.; Goulart, M.O.F.; Menna, B.R.F.S.; De Castro, S.L.; Da Silva Júnior, E.N. Synthesis and anti-Trypanosoma cruzi activity of naphthoquinone-containing triazoles: Electrochemical studies on the effects of the quinoidal moiety. Bioorg. Med. Chem., 2013, 21(21), 6337-6348.
[http://dx.doi.org/10.1016/j.bmc.2013.08.055] [PMID: 24074878];
(c) Jardim, G.A.M.; Reis, W.J.; Ribeiro, M.F.; Ottoni, F.M.; Alves, R.J.; Silva, T.L.; Goulart, M.O.F.; Braga, A.L.; Menna, B.R.F.S.; Sa-lomão, K.; De Castro, S.L.; Da Silva Júnior, E.N. On the investigation of hybrid quinones: Synthesis, electrochemical studies and evalua-tion of trypanocidal activity. RSC Advances, 2015, 5(95), 78047-78060.
[http://dx.doi.org/10.1039/C5RA16213K];
(d) Bahia, S.B.B.B.; Reis, W.J.; Jardim, G.A.M.; Souto, F.T.; de Simone, C.A.; Gatto, C.C.; Menna, B.R.F.S.; De Castro, S.L.; Cavalcanti, B.C.; Pessoa, C.; Araujo, M.H.; Da Silva, Jr E.N. Molecular hybridization as a powerful tool towards multitarget quinoidal systems: Syn-thesis, trypanocidal and antitumor activities of naphthoquinone-based 5-iodo-1,4-disubstituted-, 1,4- and 1,5-disubstituted-1,2,3-triazoles. MedChemComm, 2016, 7(8), 1555-1563.
[http://dx.doi.org/10.1039/C6MD00216A];
(e) Jardim, G.A.M.; Silva, T.L.; Goulart, M.O.F.; de Simone, C.A.; Barbosa, J.M.C.; Salomão, K.; De Castro, S.L.; Bower, J.F.; Da Silva Júnior, E.N. Rhodium-catalyzed C-H bond activation for the synthesis of quinonoid compounds: Significant anti-Trypanosoma cruzi ac-tivities and electrochemical studies of functionalized quinones. Eur. J. Med. Chem., 2017, 136, 406-419.
[http://dx.doi.org/10.1016/j.ejmech.2017.05.011] [PMID: 28521262];
(f) Jardim, G.A.M.; Oliveira, W.X.C.; De Freitas, R.P.; Menna, B.R.F.S.; Silva, T.L.; Goulart, M.O.F.; Da Silva Júnior, E.N. Direct se-quential C-H iodination/organoyl-thiolation for the benzenoid A-ring modification of quinonoid deactivated systems: A new protocol for potent trypanocidal quinones. Org. Biomol. Chem., 2018, 16(10), 1686-1691.
[http://dx.doi.org/10.1039/C8OB00196K] [PMID: 29450434];
(g) Jardim, G.A.M.; Bozzi, Í.A.O.; Oliveira, W.X.C.; Mesquita, R.C.; Menna, B.R.F.S.; Kumar, R.A.; Gravel, E.; Doris, E.; Braga, A.L.; Da Silva Júnior, E.N. Copper complexes and carbon nanotube-copper ferrite-catalyzed benzenoid A-ring selenation of quinones: An effi-cient method for the synthesis of trypanocidal agents. New J. Chem., 2019, 43(35), 13751-13763.
[http://dx.doi.org/10.1039/C9NJ02026H];
(h) Almeida, R.G.; Valença, W.O.; Rosa, L.G.; de Simone, C.A.; de Castro, S.L.; Barbosa, J.M.C.; Pinheiro, D.P.; Paier, C.R.K.; de Car-valho, G.G.C.; Pessoa, C.; Goulart, M.O.F.; Kharma, A.; da Silva Júnior, E.N. Synthesis of quinone imine and sulphur-containing com-pounds with antitumor and trypanocidal activities: Redox and biological implications. RSC Medicinal Chemistry, 2020, 11(10), 1145-1160.
[http://dx.doi.org/10.1039/D0MD00072H] [PMID: 33479619]

(a) Ellendorff, T.; Brun, R.; Kaiser, M.; Sendker, J.; Schmidt, T. PLS-prediction and confirmation of hydrojuglone glucoside as the an-titrypanosomal constituent of Juglans Spp. Molecules, 2015, 20(6), 10082-10094.
[http://dx.doi.org/10.3390/molecules200610082] [PMID: 26035104];
(b) Pacheco, P.A.F.; De Menezes, R.T.; Dos Santos, G.R.M.; Dos Santos, E.G.; Faria, A.F.M.; Von Ranke, N.L.; Bello, M.L.; Rodrigues, C.R.; Ferreira, V.F.; Souza, A.L.A.; De Jesús, H.D.; Da Silva, C.K.; Faria, R.X.; Da Rocha, D.R. Synthesis of new N,S-acetal analogs de-rived from juglone with cytotoxic activity against Trypanossoma cruzi. J. Bioenerg. Biomembr., 2020, 52(3), 199-213.
[http://dx.doi.org/10.1007/s10863-020-09834-8] [PMID: 32418003];
(c) Moideen, S.V.K.; Houghton, P.J.; Rock, P.; Croft, S.L.; Aboagye, N.F. Activity of extracts and naphthoquinones from Kigelia pinnata against Trypanosoma brucei brucei and Trypanosoma brucei rhodesiense. Planta Med., 1999, 65(6), 536-540.
[http://dx.doi.org/10.1055/s-1999-14011] [PMID: 10483374]

Rani, R.; Narasimhan, B.; Varma, R.S.; Kumar, R. Naphthoquinone derivatives exhibit apoptosis-like effect and anti-trypanosomal activi-ty against Trypanosoma evansi. Vet. Parasitol., 2021, 290, 109367.
[http://dx.doi.org/10.1016/j.vetpar.2021.109367] [PMID: 33516118]

Rani, R.; Narsiman, B.; Varma, R.S.; Kumar, R. Gum-based nanocapsules comprising naphthoquinones enhance the apoptotic and trypa-nocidal activity against Trypanosoma evansi. Eur. J. Pharm. Sci., 2022, 171, 106118.
[http://dx.doi.org/10.1016/j.ejps.2022.106118] [PMID: 35007713]

Wellington, K.W. Understanding cancer and the anticancer activities of naphthoquinones - A review. RSC Advances, 2015, 5(26), 20309-20338.
[http://dx.doi.org/10.1039/C4RA13547D]

Veskoukis, A.S.; Tsatsakis, A.M.; Kouretas, D. Dietary oxidative stress and antioxidant defense with an emphasis on plant extract ad-ministration. Cell Stress Chaperones, 2012, 17(1), 11-21.
[http://dx.doi.org/10.1007/s12192-011-0293-3] [PMID: 21956695]

Zhang, J.; Wang, X.; Vikash, V.; Ye, Q.; Wu, D.; Liu, Y.; Dong, W. ROS and ROS-mediated cellular signaling. Oxid. Med. Cell. Longev., 2016, 2016, 1-18.
[http://dx.doi.org/10.1155/2016/4350965] [PMID: 26998193]

Sharma, P.; Jha, A.B.; Dubey, R.S.; Pessarakli, M. Reactive oxygen species, oxidative damage, and antioxidative defense mechanism in plants under stressful conditions. J. Bot., 2012, 2012, 1-26.
[http://dx.doi.org/10.1155/2012/217037]

Maldonado, E.; Rojas, D.A.; Morales, S.; Miralles, V.; Solari, A. Dual and opposite roles of Reactive Oxygen Species (ROS) in Chagas disease: Beneficial on the pathogen and harmful on the host. Oxid. Med. Cell. Longev., 2020, 2020, 8867701.

Paduch, R.; Kandefer, S.M.; Piersiak, T. The importance of release of proinflammatory cytokines, ROS, and NO in different stages of colon carcinoma growth and metastasis after treatment with cytotoxic drugs. Oncol. Res., 2009, 18(9), 419-436.
[http://dx.doi.org/10.3727/096504010X12671222663593] [PMID: 20524400]

Aggarwal, V.; Tuli, H.; Varol, A.; Thakral, F.; Yerer, M.; Sak, K.; Varol, M.; Jain, A.; Khan, M.; Sethi, G. Role of reactive oxygen species in cancer progression: Molecular mechanisms and recent advancements. Biomolecules, 2019, 9(11), 735.
[http://dx.doi.org/10.3390/biom9110735] [PMID: 31766246]

Kirtonia, A.; Sethi, G.; Garg, M. The multifaceted role of reactive oxygen species in tumorigenesis. Cell. Mol. Life Sci., 2020, 77(22), 4459-4483.
[http://dx.doi.org/10.1007/s00018-020-03536-5] [PMID: 32358622]

Loor, G.; Kondapalli, J.; Schriewer, J.M.; Chandel, N.S.; Vanden, H.T.L.; Schumacker, P.T. Menadione triggers cell death through ROS-dependent mechanisms involving PARP activation without requiring apoptosis. Free Radic. Biol. Med., 2010, 49(12), 1925-1936.
[http://dx.doi.org/10.1016/j.freeradbiomed.2010.09.021] [PMID: 20937380]

Nicco, C.; Batteux, F. ROS modulator molecules with therapeutic potential in cancers treatments. Molecules, 2017, 23(1), 84.
[http://dx.doi.org/10.3390/molecules23010084] [PMID: 29301225]

Rani, R.; Kumar, S.; Dilbaghi, N.; Kumar, R. Nanotechnology enabled the enhancement of antitrypanosomal activity of piperine against Trypanosoma evansi. Exp. Parasitol., 2020, 219, 108018.
[http://dx.doi.org/10.1016/j.exppara.2020.108018] [PMID: 33049224]

Kumar, R.; Rani, R.; Kumar, S.; Sethi, K.; Jain, S.; Batra, K.; Kumar, S.; Tripathi, B.N. Drug-induced reactive oxygen species-Mediated inhibitory effect on growth of Trypanosoma evansi in axenic culture system. Parasitol. Res., 2020, 119(10), 3481-3489.
[http://dx.doi.org/10.1007/s00436-020-06861-7] [PMID: 32869169]

Kim, S.J.; Kim, H.S.; Seo, Y.R. Understanding of ROS-inducing strategy in anticancer therapy. Oxid. Med. Cell. Longev., 2019, 2019, 5381692.
[http://dx.doi.org/10.1155/2019/5381692] [PMID: 31929855]

Tavsan, Z.; Kayali, H.A. Flavonoids showed anticancer effects on the ovarian cancer cells: Involvement of reactive oxygen species, apoptosis, cell cycle and invasion. Biomed. Pharmacother., 2019, 116, 109004.
[http://dx.doi.org/10.1016/j.biopha.2019.109004] [PMID: 31128404]

Baehner, R.L.; Karnovsky, M.L. Deficiency of reduced nicotinamide-adenine dinucleotide oxidase in chronic granulomatous disease. Science, 1968, 162(3859), 1277-1279.
[http://dx.doi.org/10.1126/science.162.3859.1277] [PMID: 4387010]

Nathan, C.; Nogueira, N.; Juangbhanich, C.; Ellis, J.; Cohn, Z. Activation of macrophages in vivo and in vitro. Correlation between hydro-gen peroxide release and killing of Trypanosoma cruzi. J. Exp. Med., 1979, 149(5), 1056-1068.
[http://dx.doi.org/10.1084/jem.149.5.1056] [PMID: 376774]

Murray, H.W. Pretreatment with phorbol myristate acetate inhibits macrophage activity against intracellular protozoa. J. Reticuloendothel. Soc., 1982, 31(6), 479-487.
[PMID: 6288939]

Paiva, C.N.; Bozza, M.T. Are reactive oxygen species always detrimental to pathogens? Antioxid. Redox Signal., 2014, 20(6), 1000-1037.
[http://dx.doi.org/10.1089/ars.2013.5447] [PMID: 23992156]

Pedrosa, R.C.; De Bem, A.F.; Locatelli, C.; Pedrosa, R.C.; Geremias, R.; Filho, D.W. Time-dependent oxidative stress caused by benzni-dazole. Redox Rep., 2001, 6(4), 265-270.
[http://dx.doi.org/10.1179/135100001101536328] [PMID: 11642718]

Moreno, S.N.J.; Docampo, R.; Mason, R.P.; Leon, W.; Stoppani, A.O.M. Different behaviors of benznidazole as free radical generator with mammalian and Trypanosoma cruzi microsomal preparations. Arch. Biochem. Biophys., 1982, 218(2), 585-591.
[http://dx.doi.org/10.1016/0003-9861(82)90383-6] [PMID: 6297399]

Wilkinson, S.R.; Taylor, M.C.; Horn, D.; Kelly, J.M.; Cheeseman, I. A mechanism for cross-resistance to nifurtimox and benznidazole in trypanosomes. Proc. Natl. Acad. Sci. USA, 2008, 105(13), 5022-5027.
[http://dx.doi.org/10.1073/pnas.0711014105] [PMID: 18367671]

Trochine, A.; Creek, D.J.; Faral, T.P.; Barrett, M.P.; Robello, C. Benznidazole biotransformation and multiple targets in Trypanosoma cruzi revealed by metabolomics. PLoS Negl. Trop. Dis., 2014, 8(5), e2844.
[http://dx.doi.org/10.1371/journal.pntd.0002844] [PMID: 24853684]

Hall, B.S.; Wilkinson, S.R. Activation of benznidazole by trypanosomal type I nitroreductases results in glyoxal formation. Antimicrob. Agents Chemother., 2012, 56(1), 115-123.
[http://dx.doi.org/10.1128/AAC.05135-11] [PMID: 22037852]

Rigalli, J.P.; Perdomo, V.G.; Ciriaci, N.; Francés, D.E.A.; Ronco, M.T.; Bataille, A.M.; Ghanem, C.I.; Ruiz, M.L.; Manautou, J.E.; Catania, V.A. The trypanocidal benznidazole promotes adaptive response to oxidative injury: Involvement of the Nuclear Factor-Erythroid 2-Related Factor-2 (Nrf2) and Multidrug Resistance Associated Protein 2 (MRP2). Toxicol. Appl. Pharmacol., 2016, 304, 90-98.
[http://dx.doi.org/10.1016/j.taap.2016.05.007] [PMID: 27180241]

Lara, F.A.; Sant’Anna, C.; Lemos, D.; Laranja, G.A.T.; Coelho, M.G.P.; Reis Salles, I.; Michel, A.; Oliveira, P.L.; Cunha-e-Silva, N.; Salmon, D.; Paes, M.C. Heme requirement and intracellular trafficking in Trypanosoma cruzi epimastigotes. Biochem. Biophys. Res. Commun., 2007, 355(1), 16-22.
[http://dx.doi.org/10.1016/j.bbrc.2006.12.238] [PMID: 17292866]

Ferreira, C.M.; Stiebler, R.; Saraiva, F.M.; Lechuga, G.C.; Walter, N.A.B.; Bourguignon, S.C.; Gonzalez, M.S.; Azambuja, P.; Gandara, A.C.P.; Menna, B.R.F.S.; Paiva, S.G.O.; Paes, M.C.; Oliveira, M.F. Heme crystallization in a Chagas disease vector acts as a redox-protective mechanism to allow insect reproduction and parasite infection. PLoS Negl. Trop. Dis., 2018, 12(7), e0006661.
[http://dx.doi.org/10.1371/journal.pntd.0006661] [PMID: 30036366]

Finzi, J.; Chiavegatto, C.W.; Corat, K.F.; Lopez, J.A.; Cabrera, O.G.; Mielniczki, P.A.A.; Colli, W.; Alves, M.J.M.; Gadelha, F.R. Trypano-soma cruzi response to the oxidative stress generated by hydrogen peroxide. Mol. Biochem. Parasitol., 2004, 133(1), 37-43.
[http://dx.doi.org/10.1016/j.molbiopara.2003.08.011] [PMID: 14668010]

Graçasouza, A.; Mayamonteiro, C.; Paivasilva, G.; Braz, G.; Paes, M.; Sorgine, M.; Oliveira, M.; Oliveira, P. Adaptations against heme toxicity in blood-feeding arthropods. Insect Biochem. Mol. Biol., 2006, 36(4), 322-335.
[http://dx.doi.org/10.1016/j.ibmb.2006.01.009] [PMID: 16551546]

Paiva, S.G.O.; Cruz, O.C.; Nakayasu, E.S.; H., Dunkov B.C.; Masuda, H.; Almeida, I.C.; Oliveira, P.L. A heme-degradation pathway in a blood-sucking insect. Proc. Natl. Acad. Sci. USA, 2006, 103(21), 8030-8035.
[http://dx.doi.org/10.1073/pnas.0602224103] [PMID: 16698925]

Boveris, A.; Docampo, R.; Turrens, J.F.; Stoppani, A.O. [Effect of beta and alpha-lapachone on the production of H202 and on the growth of Trypanosoma cruzi. Rev. Asoc. Argent. Microbiol., 1977, 9(2), 54-61.
[PMID: 339293]

Boveris, A.; Stoppani, A.O.M.; Docampo, R.; Cruz, F.S. Superoxide anion production and trypanocidal action of naphthoquinones on Trypanosoma cruzi. Comp. Biochem. Physiol. C Comp. Pharmacol., 1978, 61(2), 327-329.
[http://dx.doi.org/10.1016/0306-4492(78)90063-1] [PMID: 33002]

Docampo, R.; Souza, W.; Cruz, F.S.; Roitman, I.; Cover, B.; Gutteridge, W.E. Ultrastructural alterations and peroxide formation induced by naphthoquinones in different stages of Trypanosoma cruzi. Z. Parasitenkd., 1978, 57(3), 189-198.
[http://dx.doi.org/10.1007/BF00928032] [PMID: 216177]

Docampo, R.; Lopes, J.N.; Cruz, F.S.; De Souza, W. Trypanosoma cruzi: Ultrastructural and metabolic alterations of epimastigotes by β-lapachone. Exp. Parasitol., 1977, 42(1), 142-149.
[http://dx.doi.org/10.1016/0014-4894(77)90071-6] [PMID: 324785]

Goijman, S.G.; Stoppani, A.O.M. Effects of β-lapachone, a peroxide-generating quinone, on macromolecule synthesis and degradation in Trypanosoma cruzi. Arch. Biochem. Biophys., 1985, 240(1), 273-280.
[http://dx.doi.org/10.1016/0003-9861(85)90033-5] [PMID: 2409922]

Goijman, S.G.; Stoppani, A.O. Effects of nifurtimox, benznidazole, and beta-lapachone on the metabolism of DNA, RNA and proteins in Trypanosoma cruzi. Rev. Argent. Microbiol., 1983, 15(4), 193-204.
[PMID: 6086046]

De Tarlovsky, S.M.N.; Goijman, S.G.; Molina, P.M.P.; Stoppani, A.O.M. Effects of isoxazolyl-naphthoquinoneimines on growth and oxygen radical production in Trypanosoma cruzi and Crithidia fasciculata. Experientia, 1990, 46(5), 502-505.
[http://dx.doi.org/10.1007/BF01954247] [PMID: 2189749]

Li, C.J.; Wang, C.; Pardee, A.B. Induction of apoptosis by beta-lapachone in human prostate cancer cells. Cancer Res., 1995, 55(17), 3712-3715.
[PMID: 7641181]

Dubin, M.; Fernandez, V.S.H.; Stoppani, A.O. Cytotoxicity of beta-lapachone, an naphthoquinone with possible therapeutic use. Medicina (B. Aires), 2001, 61(3), 343-350.
[PMID: 11474885]

Planchon, S.M.; Pink, J.J.; Tagliarino, C.; Bornmann, W.G.; Varnes, M.E.; Boothman, D.A. beta-Lapachone-induced apoptosis in human prostate cancer cells: Involvement of NQO1/xip3. Exp. Cell Res., 2001, 267(1), 95-106.
[http://dx.doi.org/10.1006/excr.2001.5234] [PMID: 11412042]

Neder, K.; Marton, L.J.; Liu, L.F.; Frydman, B. Reaction of beta-lapachone and related naphthoquinones with 2-mercaptoethanol: A biomimetic model of topoisomerase II poisoning by quinones. Cell. Mol. Biol., 1998, 44(3), 465-474.
[PMID: 9620443]

Krishnan, P.; Bastow, K.F. Novel mechanism of cellular DNA topoisomerase II inhibition by the pyranonaphthoquinone derivatives α-lapachone and β-lapachone. Cancer Chemother. Pharmacol., 2001, 47(3), 187-198.
[http://dx.doi.org/10.1007/s002800000221] [PMID: 11320661]

Pink, J.J.; Planchon, S.M.; Tagliarino, C.; Varnes, M.E.; Siegel, D.; Boothman, D.A. NAD(P)H:Quinone oxidoreductase activity is the principal determinant of beta-lapachone cytotoxicity. J. Biol. Chem., 2000, 275(8), 5416-5424.
[http://dx.doi.org/10.1074/jbc.275.8.5416] [PMID: 10681517]

Pink, J.J.; Wuerzberger, D.S.; Tagliarino, C.; Planchon, S.M.; Yang, X.; Froelich, C.J.; Boothman, D.A. Activation of a cysteine protease in MCF-7 and T47D breast cancer cells during beta-lapachone-mediated apoptosis. Exp. Cell Res., 2000, 255(2), 144-155.
[http://dx.doi.org/10.1006/excr.1999.4790] [PMID: 10694431]

Esteves, S.A.; Figueiredo, D.V.; Esteves, A.; Câmara, C.A.; Vargas, M.D.; Pinto, A.C.; Echevarria, A. Cytotoxic and DNA-topoisomerase effects of lapachol amine derivatives and interactions with DNA. Braz. J. Med. Biol. Res., 2007, 40(10), 1399-1402.
[http://dx.doi.org/10.1590/S0100-879X2006005000159] [PMID: 17713652]

Salustiano, E.J.S.; Netto, C.D.; Fernandes, R.F.; Da Silva, A.J.M.; Bacelar, T.S.; Castro, C.P.; Buarque, C.D.; Maia, R.C.; Rumjanek, V.M.; Costa, P.R.R. Comparison of the cytotoxic effect of lapachol, α-lapachone and pentacyclic 1,4-naphthoquinones on human leukemic cells. Invest. New Drugs, 2010, 28(2), 139-144.
[http://dx.doi.org/10.1007/s10637-009-9231-y] [PMID: 19255723]

Lopez, L.M.; Dubin, M.; Carrizo, P.H.; Burgos, M.H.; De Iraldi, P.A.; Stoppani, A.O. Apoptogenic effect of the lipophilic o-naphthoquinone CG 10-248 on rat hepatocytes: Light and electron microscopy studies. Biocell, 2003, 27(2), 213-224.
[http://dx.doi.org/10.32604/biocell.2003.27.213] [PMID: 14510240]

Menna, B.R.F.S.; Corrêa, J.R.; Cascabulho, C.M.; Fernandes, M.C.; Pinto, A.V.; Soares, M.J.; De Castro, S.L. Naphthoimidazoles pro-mote different death phenotypes in Trypanosoma cruzi. Parasitology, 2009, 136(5), 499-510.
[http://dx.doi.org/10.1017/S0031182009005745] [PMID: 19281638]

Salomão, K.; De Santana, N.A.; Molina, M.T.; De Castro, S.L.; Menna, B.R.F.S. Trypanosoma cruzi mitochondrial swelling and mem-brane potential collapse as primary evidence of the mode of action of naphthoquinone analogues. BMC Microbiol., 2013, 13(1), 196.
[http://dx.doi.org/10.1186/1471-2180-13-196] [PMID: 24004461]

Bombaça, A.C.S.; Viana, P.G.; Santos, A.C.C.; Silva, T.L.; Rodrigues, A.B.M.; Guimarães, A.C.R.; Goulart, M.O.F.; Da Silva Júnior, E.N.; Menna, B.R.F.S. Mitochondrial disfunction and ROS production are essential for anti-Trypanosoma cruzi activity of β-lapachone-derived naphthoimidazoles. Free Radic. Biol. Med., 2019, 130, 408-418.
[http://dx.doi.org/10.1016/j.freeradbiomed.2018.11.012] [PMID: 30445126]

Dos Anjos, D.O.; Sobral, A.E.S.; Gonçalves, V.T.; Fontes, S.S.; Nogueira, M.L.; Suarez, F.A.M.; Da Costa, F.J.B.; Rios, S.F.; Vannier, S.M.A. Effects of a novel β-lapachone derivative on Trypanosoma cruzi: Parasite death involving apoptosis, autophagy and necrosis. Int. J. Parasitol. Drugs Drug Resist., 2016, 6(3), 207-219.
[http://dx.doi.org/10.1016/j.ijpddr.2016.10.003] [PMID: 27770751]

Paes, M.C.; Cosentino, G.D.; Souza, C.F.; Nogueira, N.P.A.; Meyer, F.J.R. The role of heme and reactive oxygen species in proliferation and survival of Trypanosoma cruzi. J. Parasitol. Res., 2011, 2011, 174614.
[http://dx.doi.org/10.1155/2011/174614] [PMID: 22007287]

Manta, B.; Comini, M.; Medeiros, A.; Hugo, M.; Trujillo, M.; Radi, R. Trypanothione: A unique bis-glutathionyl derivative in trypano-somatids. Biochim. Biophys. Acta, Gen. Subj., 2013, 1830(5), 3199-3216.
[http://dx.doi.org/10.1016/j.bbagen.2013.01.013] [PMID: 23396001]

Oza, S.L.; Tetaud, E.; Ariyanayagam, M.R.; Warnon, S.S.; Fairlamb, A.H. A single enzyme catalyses formation of Trypanothione from glutathione and spermidine in Trypanosoma cruzi. J. Biol. Chem., 2002, 277(39), 35853-35861.
[http://dx.doi.org/10.1074/jbc.M204403200] [PMID: 12121990]

Mesías, A.C.; Garg, N.J.; Zago, M.P. Redox balance keepers and possible cell functions managed by redox homeostasis in Trypanosoma cruzi. Front. Cell. Infect. Microbiol., 2019, 9, 435.
[http://dx.doi.org/10.3389/fcimb.2019.00435] [PMID: 31921709]

Irigoín, F.; Cibils, L.; Comini, M.A.; Wilkinson, S.R.; Flohé, L.; Radi, R. Insights into the redox biology of Trypanosoma cruzi: Trypano-thione metabolism and oxidant detoxification. Free Radic. Biol. Med., 2008, 45(6), 733-742.
[http://dx.doi.org/10.1016/j.freeradbiomed.2008.05.028] [PMID: 18588970]

De Figueiredo, P.E.; Vitor, S.C.; Ribeiro, L.H.G.; Piñeyro, M.D.; Robello, C.; Gadelha, F.R. Role of Trypanosoma cruzi peroxiredoxins in mitochondrial bioenergetics. J. Bioenerg. Biomembr., 2011, 43(4), 419-424.
[http://dx.doi.org/10.1007/s10863-011-9365-4] [PMID: 21732175]

Arnér, E.S.J.; Holmgren, A. Physiological functions of thioredoxin and thioredoxin reductase. Eur. J. Biochem., 2000, 267(20), 6102-6109.
[http://dx.doi.org/10.1046/j.1432-1327.2000.01701.x] [PMID: 11012661]

Ariyanayagam, M.; Fairlamb, A.H. Ovothiol and trypanothione as antioxidants in trypanosomatids. Mol. Biochem. Parasitol., 2001, 115(2), 189-198.
[http://dx.doi.org/10.1016/S0166-6851(01)00285-7] [PMID: 11420105]

Krauth, S.R.L.; Inhoff, O. Parasite-specific trypanothione reductase as a drug target molecule. Parasitol. Res., 2003, 90(0)(Suppl. 2), S77-S85.
[http://dx.doi.org/10.1007/s00436-002-0771-8] [PMID: 12709793]

Comini, M.A.; Guerrero, S.A.; Haile, S.; Menge, U.; Lünsdorf, H.; Flohé, L. Valdiation of Trypanosoma brucei trypanothione synthetase as drug target. Free Radic. Biol. Med., 2004, 36(10), 1289-1302.
[http://dx.doi.org/10.1016/j.freeradbiomed.2004.02.008] [PMID: 15110394]

Khan, M.O.F. Trypanothione reductase: A viable chemotherapeutic target for antitrypanosomal and antileishmanial drug design. Drug Target Insights, 2007, 2, 129-146.
[http://dx.doi.org/10.1177/117739280700200007] [PMID: 21901070]

Benítez, D.; Medeiros, A.; Fiestas, L.; Panozzo, Z.E.A.; Maiwald, F.; Prousis, K.C.; Roussaki, M.; Calogeropoulou, T.; Detsi, A.; Jaeger, T.; Šarlauskas, J.; Peterlin Mašič, L.; Kunick, C.; Labadie, G.R.; Flohé, L.; Comini, M.A. Identification of novel chemical scaffolds inhib-iting trypanothione synthetase from pathogenic trypanosomatids. PLoS Negl. Trop. Dis., 2016, 10(4), e0004617.
[http://dx.doi.org/10.1371/journal.pntd.0004617] [PMID: 27070550]

Mendonça, A.A.S.; Coelho, C.M.; Veloso, M.P.; Caldas, I.S.; Gonçalves, R.V.; Teixeira, A.L.; De Miranda, A.S.; Novaes, R.D. Relevance of trypanothione reductase inhibitors on Trypanosoma cruzi infection: A systematic review, meta-analysis, and in silico integrated ap-proach. Oxid. Med. Cell. Longev., 2018, 2018, 1-20.
[http://dx.doi.org/10.1155/2018/8676578] [PMID: 30473742]

Battista, T.; Colotti, G.; Ilari, A.; Fiorillo, A. Targeting trypanothione reductase, a key enzyme in the redox trypanosomatid metabolism, to develop new drugs against Leishmaniasis and Trypanosomiases. Molecules, 2020, 25(8), 1924.
[http://dx.doi.org/10.3390/molecules25081924] [PMID: 32326257]

Henderson, G.B.; Ulrich, P.; Fairlamb, A.H.; Rosenberg, I.; Pereira, M.; Sela, M.; Cerami, A. “Subversive” substrates for the enzyme trypanothione disulfide reductase: Alternative approach to chemotherapy of Chagas disease. Proc. Natl. Acad. Sci. USA, 1988, 85(15), 5374-5378.
[http://dx.doi.org/10.1073/pnas.85.15.5374] [PMID: 3135548]

Cenas, N.K.; Arscott, D.; Williams, C.H., Jr; Blanchard, J.S. Mechanism of reduction of quinones by Trypanosoma congolense trypano-thione reductase. Biochemistry, 1994, 33(9), 2509-2515.
[http://dx.doi.org/10.1021/bi00175a021] [PMID: 8117712]

Salmon, C.L.; Buisine, E.; Yardley, V.; Kohler, S.; Debreu, M.A.; Landry, V.; Sergheraert, C.; Croft, S.L.; Krauth, S.R.L.; Davioud, C.E. 2- and 3-substituted 1,4-naphthoquinone derivatives as subversive substrates of trypanothione reductase and lipoamide dehydrogenase from Trypanosoma cruzi: Synthesis and correlation between redox cycling activities and in vitro cytotoxicity. J. Med. Chem., 2001, 44(4), 548-565.
[http://dx.doi.org/10.1021/jm001079l] [PMID: 11170645]

Zani, C.L.; Fairlamb, A.H. 8-Methoxy-naphtho[2,3-b]thiophen-4,9-quinone, a non-competitive inhibitor of trypanothione reductase. Mem. Inst. Oswaldo Cruz, 2003, 98(4), 565-568.
[http://dx.doi.org/10.1590/S0074-02762003000400026] [PMID: 12937775]

Lara, L.S.; Moreira, C.S.; Calvet, C.M.; Lechuga, G.C.; Souza, R.S.; Bourguignon, S.C.; Ferreira, V.F.; Rocha, D.; Pereira, M.C.S. Efficacy of 2-hydroxy-3-phenylsulfanylmethyl-[1,4]-naphthoquinone derivatives against different Trypanosoma cruzi discrete type units: Identi-fication of a promising hit compound. Eur. J. Med. Chem., 2018, 144, 572-581.
[http://dx.doi.org/10.1016/j.ejmech.2017.12.052] [PMID: 29289882]

Ribeiro, G.A.; Cunha-Júnior, E.F.; Pinheiro, R.O.; Da Silva, S.A.G.; Canto, C.M.M.; Da Silva, A.J.M.; Costa, P.R.R.; Netto, C.D.; Melo, R.C.N.; Almeida, A.E.E.; Torres, S.E.C. LQB-118, an orally active pterocarpanquinone, induces selective oxidative stress and apoptosis in Leishmania amazonensis. J. Antimicrob. Chemother., 2013, 68(4), 789-799.
[http://dx.doi.org/10.1093/jac/dks498] [PMID: 23288404]

Awasthi, B.P.; Kathuria, M.; Pant, G.; Kumari, N.; Mitra, K. Plumbagin, a plant-derived naphthoquinone metabolite induces mitochondria mediated apoptosis-like cell death in Leishmania donovani: An ultrastructural and physiological study. Apoptosis, 2016, 21(8), 941-953.
[http://dx.doi.org/10.1007/s10495-016-1259-9] [PMID: 27315817]

Enayat, S.; Şeyma, C.M.; Taşkoparan, B.; Stefek, M.; Banerjee, S. CHNQ, a novel 2-Chloro-1,4-naphthoquinone derivative of quercetin, induces oxidative stress and autophagy both in vitro and in vivo. Arch. Biochem. Biophys., 2016, 596, 84-98.
[http://dx.doi.org/10.1016/j.abb.2016.03.004] [PMID: 26946942]

Bombaça, A.C.S.; Silva, L.A.; Chaves, O.A.; Da Silva, L.S.; Barbosa, J.M.C.; Da Silva, A.M.; Ferreira, A.B.B.; Menna, B.R.F.S.; Novel, N.; Novel, N. N-di-alkylnaphthoimidazolium derivative of β-lapachone impaired Trypanosoma cruzi mitochondrial electron transport sys-tem. Biomed. Pharmacother., 2021, 135, 111186.
[http://dx.doi.org/10.1016/j.biopha.2020.111186] [PMID: 33395606]

Wang, J.; Zeng, G.; Huang, X.; Wang, Z.; Tan, N. 1, 4-naphtho-] quinone triggers nematode lethality by inducing oxidative stress and activating insulin/IGF signaling pathway in Caenorhabditis elegans. Molecules, 2017, 22(5), 798.
[http://dx.doi.org/10.3390/molecules22050798] [PMID: 28505088]

Docampo, R.; Cruz, F.S.; Boveris, A.; Muniz, R.P.A.; Esquivel, D.M.S. Lipid peroxidation and the generation of free radicals, superoxide anion, and hydrogen peroxide in β-lapachone-treated Trypanosoma cruzi epimastigotes. Arch. Biochem. Biophys., 1978, 186(2), 292-297.
[http://dx.doi.org/10.1016/0003-9861(78)90438-1] [PMID: 205176]

Molina, P.M.P.; Fernandez, V.S.H.; Perissinotti, L.J.; Stoppani, A.O. Redox cycling of o-naphthoquinones in trypanosomatids. Superox-ide and hydrogen peroxide production. Biochem. Pharmacol., 1996, 52(12), 1875-1882.
[http://dx.doi.org/10.1016/S0006-2952(96)00601-6] [PMID: 8951346]

Gong, Q.; Hu, J.; Wang, P.; Li, X.; Zhang, X. A comprehensive review on β-lapachone: Mechanisms, structural modifications, and thera-peutic potentials. Eur. J. Med. Chem., 2021, 210, 112962.
[http://dx.doi.org/10.1016/j.ejmech.2020.112962] [PMID: 33158575]

Walton, M.I.; Wolf, C.R.; Workman, P. The role of cytochrome P450 and cytochrome P450 reductase in the reductive bioactivation of the novel benzotriazine di-N-oxide hypoxic cytotoxin 3-amino-1,2,4-benzotriazine-1,4-dioxide (SR 4233, WIN 59075) by mouse liver. Biochem. Pharmacol., 1992, 44(2), 251-259.
[http://dx.doi.org/10.1016/0006-2952(92)90007-6] [PMID: 1642640]

García, B.P.M.; Lamoureux, G.V.; Pérez, A.L.; García, S.R.N.; Martínez, A.R.; San Feliciano, A. Synthesis and biological evaluation of novel ferrocene-naphthoquinones as antiplasmodial agents. Eur. J. Med. Chem., 2013, 70, 548-557.
[http://dx.doi.org/10.1016/j.ejmech.2013.10.011] [PMID: 24211630]

Kumagai, Y.; Shinkai, Y.; Miura, T.; Cho, A.K. The chemical biology of naphthoquinones and its environmental implications. Annu. Rev. Pharmacol. Toxicol., 2012, 52(1), 221-247.
[http://dx.doi.org/10.1146/annurev-pharmtox-010611-134517] [PMID: 21942631]

Shang, Y.; Chen, C.; Li, Y.; Zhao, J.; Zhu, T. Hydroxyl radical generation mechanism during the redox cycling process of 1,4-naphthoquinone. Environ. Sci. Technol., 2012, 46(5), 2935-2942.
[http://dx.doi.org/10.1021/es203032v] [PMID: 22288565]

Gurbani, D.; Bharti, S.K.; Kumar, A.; Pandey, A.K.; Ana, G.R.E.E.; Verma, A.; Khan, A.H.; Patel, D.K.; Mudiam, M.K.R.; Jain, S.K.; Roy, R.; Dhawan, A. Polycyclic aromatic hydrocarbons and their quinones modulate the metabolic profile and induce DNA damage in human alveolar and bronchiolar cells. Int. J. Hyg. Environ. Health, 2013, 216(5), 553-565.
[http://dx.doi.org/10.1016/j.ijheh.2013.04.001] [PMID: 23735462]

Bolton, J.L.; Dunlap, T. Formation and biological targets of quinones: Cytotoxic versus cytoprotective effects. Chem. Res. Toxicol., 2017, 30(1), 13-37.
[http://dx.doi.org/10.1021/acs.chemrestox.6b00256] [PMID: 27617882]

Ahn, K.J.; Lee, H.S.; Bai, S.K.; Song, C.W. Enhancement of radiation effect using beta-lapachone and underlying mechanism. Radiat. Oncol. J., 2013, 31(2), 57-65.
[http://dx.doi.org/10.3857/roj.2013.31.2.57] [PMID: 23865001]

Park, E.J.; Min, K.; Lee, T.J.; Yoo, Y.H.; Kim, Y.S.; Kwon, T.K. β-Lapachone induces programmed necrosis through the RIP1-PARP-AIF-dependent pathway in human hepatocellular carcinoma SK-Hep1 cells. Cell Death Dis., 2014, 5(5), e1230.
[http://dx.doi.org/10.1038/cddis.2014.202] [PMID: 24832602]

Dubin, M.; Villamil, S.H.F.; Stoppani, A.O.M. Inhibition of microsomal lipid peroxidation and cytochrome P-450-catalyzed reactions by β-lapachone and related naphthoquinones. Biochem. Pharmacol., 1990, 39(7), 1151-1160.
[http://dx.doi.org/10.1016/0006-2952(90)90256-K] [PMID: 2157443]

De Witte, N.V.; Stoppani, A.O.M.; Dubin, M. 2-Phenyl-β-lapachone can affect mitochondrial function by redox cycling mediated oxida-tion. Arch. Biochem. Biophys., 2004, 432(2), 129-135.
[http://dx.doi.org/10.1016/j.abb.2004.09.020] [PMID: 15542051]

Portela, M.P.M.; Stoppani, A.O.M. Redox cycling of β-lapachone and related o-naphthoquinones in the presence of dihydrolipoamide and oxygen. Biochem. Pharmacol., 1996, 51(3), 275-283.
[http://dx.doi.org/10.1016/0006-2952(95)02168-X] [PMID: 8573194]

Paulino, M.; Alvareda, E.M.; Denis, P.A.; Barreiro, E.J.; Da Silva, S.G.M.; Dubin, M.; Gastellú, C.; Aguilera, S.; Tapia, O. Studies of trypanocidal (inhibitory) power of naphthoquinones: Evaluation of quantum chemical molecular descriptors for structure-activity rela-tionships. Eur. J. Med. Chem., 2008, 43(10), 2238-2246.
[http://dx.doi.org/10.1016/j.ejmech.2007.12.023] [PMID: 18276039]

Garavaglia, P.A.; Rubio, M.F.; Laverrière, M.; Tasso, L.M.; Fichera, L.E.; Cannata, J.J.B.; García, G.A. Trypanosoma cruzi: Death pheno-types induced by ortho-naphthoquinone substrates of the aldo-keto reductase (Tc AKR). Role of this enzyme in the mechanism of action of β -lapachone. Parasitology, 2018, 145(9), 1251-1259.
[http://dx.doi.org/10.1017/S0031182018000045] [PMID: 29400267]